Deutsche Bank’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History
Bought
Maintained
Sold
Other funds holding CELGZ
CC
BC
FA
DC
CL
MSTVIM
Deutsche Bank's CELGZ Position: Q4 2017 in Review
Deutsche Bank sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2017, closing a stake of 10,000 shares — an estimated $15K sold.
Deutsche Bank first reported a position in CELGZ in Q2 2013 and held it in 18 quarters. The position peaked at $484K in Q3 2013. 19 funds tracked by Wall St. Rank hold CELGZ as of Q4 2017.
- Deutsche Bank reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2017 after selling out during the quarter.
- Deutsche Bank sold 10,000 Celgene Corporation Contingent Value Rights shares in Q4 2017, an estimated $15K.
- Deutsche Bank first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and held it in 18 quarters.
- Deutsche Bank's Celgene Corporation Contingent Value Rights position peaked at $484K in Q3 2013.
- 19 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2017.
Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.